Results for "pharmaceuticals".

Recursion Pharmaceuticals May Be Losing Ground To Its Peers

Recursion Pharmaceuticals' AI-driven Recursion OS platform shows strong potential but has yet to demonstrate a clear competitive edge. Read more on RXRX stock here.…

Earnings call transcript: Santhera Pharmaceuticals’ H2 2025 revenue doubles

Rocket Pharmaceuticals sells priority review voucher for $180M

Form 13G Indivior Pharmaceuticals Inc For: 27 April